Kiromic Biopharma files for Chapter 7 bankruptcy
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kiromic Biopharma Inc (KRBPQ)
Kiromic Biopharma Inc stock price live, this page displays OTC KRBPQ stock exchange data. View the KRBPQ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kiromic Biopharma Inc real time stock price chart below.
What Is the Kiromic Biopharma Inc Stock Price Today?
The Kiromic Biopharma Inc stock price today is 0.004.
What Is the Stock Symbol for Kiromic Biopharma Inc?
The stock symbol for Kiromic Biopharma Inc is ""KRBPQ.""
What Stock Exchange Does Kiromic Biopharma Inc Trade On?
Kiromic Biopharma Inc is listed and trades on the OTC Markets stock exchange.
Is Kiromic Biopharma Inc a Good Stock to Buy?
Determining whether Kiromic Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KRBPQ quote. (ISIN: US4976342042)
What Is the Kiromic Biopharma Inc Stock Price Today?
The Kiromic Biopharma Inc stock price today is 0.004.
What Is the Stock Symbol for Kiromic Biopharma Inc?
The stock symbol for Kiromic Biopharma Inc is ""KRBPQ.""
What Stock Exchange Does Kiromic Biopharma Inc Trade On?
Kiromic Biopharma Inc is listed and trades on the OTC Markets stock exchange.
Is Kiromic Biopharma Inc a Good Stock to Buy?
Determining whether Kiromic Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KRBPQ quote. (ISIN: US4976342042)
OTC Markets
Currency in USD
0.004
-0.002(-33.33%)
Closed·
Fair Value
An estimate of a Kiromic's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.004
0.004
52 wk Range
0.004
2.400
KRBPQ Scorecard
Full Analysis
Stock has taken a big hit over the last week
Trading near 52-week Low
More Info
Fair Value
An estimate of a Kiromic's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0040.004
52 wk Range
0.0042.400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KRBPQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kiromic's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Kiromic BioPharma swaps debt for preferred stock
- Investing.com
- Kiromic Biopharma files for Chapter 7 bankruptcy
- Investing.com
- Kiromic Biopharma issues $2 million convertible note
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Kiromic Biopharma Inc Company Profile
Kiromic BioPharma, Inc., a clinical stage biotherapeutics company, engages in the utilization of non-engineered an engineered allogeneic Gamma Delta T (GDT) cell technologies to develop therapies for solid tumors in the United States. The company’s lead product candidate is the Deltacel-01, which is in Phase 1 clinical trial, in combination with low-dose targeted radiation for patients with non-small cell lung cancer. It also develops Isocel, which is clinical trial in combination with low-dose radiation to treat Mesothelin Isoform 2 positive solid malignancies; Procel, which is in clinical trial in combination with low-dose radiation to treat PD-L1 positive solid malignancies; ALEXIS-ISO-1, which is in clinical trial to evaluate Isocel in patients with Mesothelin Isoform 2 positive solid malignancies; and ALEXIS-PRO-1, which is in clinical trial to evaluate Procel in patients with PD-L1 positive solid malignancies. It has a license agreement with Longwood University. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. On March 21, 2025, Kiromic BioPharma, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Compare KRBPQ to Peers and Sector
Metrics to compare | KRBPQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKRBPQPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −5.0x | −0.5x | |
PEG Ratio | 0.00 | −0.11 | 0.00 | |
Price/Book | 0.0x | 3.3x | 2.6x | |
Price / LTM Sales | 0.0x | 10.0x | 3.3x | |
Upside (Analyst Target) | 0.0% | 125.5% | 42.8% | |
Fair Value Upside | Unlock | −3.1% | 6.5% | Unlock |
Earnings
Latest Release
Feb 14, 2025
EPS / Forecast
13.13 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Kiromic Trade On?
Kiromic is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Kiromic?
The stock symbol for Kiromic is "KRBPQ."
What Is the Kiromic Market Cap?
As of today, Kiromic market cap is 6.28K.
What Is Kiromic's Earnings Per Share (TTM)?
The Kiromic EPS (TTM) is -3.17.
From a Technical Analysis Perspective, Is KRBPQ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Kiromic Stock Split?
Kiromic has split 1 times.
How Many Employees Does Kiromic Have?
Kiromic has 44 employees.
What is the current trading status of Kiromic (KRBPQ)?
As of 06 Aug 2025, Kiromic (KRBPQ) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 2.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.